JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 16, 2009, 10.2967/jnumed.109.065151
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.109.065151v1
50/10/1611    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Rominger, A.
Right arrow Articles by Hacker, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rominger, A.
Right arrow Articles by Hacker, M.
Journal of Nuclear Medicine Vol. 50 No. 10 1611-1620
© 2009 by Society of Nuclear Medicine

doi: 10.2967/jnumed.109.065151

Clinical Investigation

18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease

Axel Rominger*,1, Tobias Saam*,2, Sarah Wolpers1, Clemens C. Cyran2, Michael Schmidt3, Stefan Foerster1, Konstantin Nikolaou2, Maximilian F. Reiser2, Peter Bartenstein1 and Marcus Hacker1

1 Department of Nuclear Medicine, University of Munich, Munich, Germany; 2 Institute of Clinical Radiology, University of Munich, Munich, Germany; and 3 Institute of Medical Informatics, Biometrics and Epidemiology, University of Munich, Munich, Germany

Correspondence: For correspondence or reprints contact: Marcus Hacker, Department of Nuclear Medicine, University of Munich, Marchioninistrasse 15, 81377 München, Germany. E-mail: marcus.hacker{at}med.uni-muenchen.de

Our objective was to evaluate the association of arterial 18F-FDG uptake and calcifications in large arteries as detected by 18F-FDG PET/CT with the subsequent occurrence of vascular events in otherwise asymptomatic cancer patients. Methods: Clinical follow-up information was obtained for 932 cancer patients examined with whole-body 18F-FDG PET/CT (median follow-up time, 29 mo). Among this cohort, 279 patients had died from their oncologic disease. In 15 of 932 patients (1.6%), a vascular event, defined as ischemic stroke, myocardial infarction, or revascularization, was registered. The maximal standardized uptake value (SUV) was divided by the blood-pool SUV, yielding a target-to-background ratio (TBR) for each arterial segment. The mean TBR as well as a calcified plaque sum score per patient were calculated in the major vessels: ascending, descending, and abdominal aorta, aortic arch, as well as iliac and carotid arteries. Results: A significant correlation was observed between mean TBR and calcified plaque sum (P < 0.001). Although calcified plaque sum significantly correlated with all conventional risk factors for vascular events, mean TBR correlated only with age, the male sex, and hypertension. The Cox regression hazard model identified a mean TBR ≥ 1.7 and a calcified plaque sum ≥ 15 as independent predictors for the occurrence of a vascular event. Patients with both mean TBR and calcified plaque sum above these thresholds were identified as having the highest risk for a future vascular event. However, a mean TBR ≥ 1.7 had greater prognostic value than did a calcified plaque sum ≥ 15. Conclusion: In a large cohort of cancer patients, increased 18F-FDG uptake in major arteries emerged as the strongest predictor of a subsequent vascular event. Concomitant severe vascular calcifications seemed to impart a particularly high risk. Given the small event rate in the present study, larger, prospective trials of patients without cancer are required to substantiate these promising results.

Key Words: atherosclerosis • plaque • risk factors • imaging • PET/CT

* Contributed equally to this work.

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
A. Rominger, T. Saam, E. Vogl, C. Ubleis, C. la Fougere, S. Forster, A. Haug, P. Cumming, M. F. Reiser, K. Nikolaou, et al.
In Vivo Imaging of Macrophage Activity in the Coronary Arteries Using 68Ga-DOTATATE PET/CT: Correlation with Coronary Calcium Burden and Risk Factors
J. Nucl. Med., February 1, 2010; 51(2): 193 - 197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.